Analysis of the urine proteome in patients with pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

Analysis of the urine proteome in patients with pancreatic ductal adenocarcinoma

Published:2008-07 Issue:7-8 Volume:2 Page:1047-1057
ISSN:1862-8346
Container-title:PROTEOMICS - CLINICAL APPLICATIONS
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Weeks Mark E.,Hariharan Deepak,Petronijevic Ljiljana,Radon Tomasz P.,Whiteman Hannah J.,Kocher Hemant M.,Timms John F.,Lemoine Nicholas R.,Crnogorac-Jurcevic Tatjana

Publisher

Wiley

Subject

Clinical Biochemistry

Reference53 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J. Clin.,2007

2. Pancreatic cancer: A report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database;Sener;J. Am. Coll. Surg.,1999

3. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer;Locker;J. Clin. Oncol.,2006

4. Clinicopathological aspects of small pancreatic cancer;Egawa;Pancreas,2004

5. Early detection of pancreatic carcinoma;Rosty;Hematol. Oncol. Clin. North Am.,2002

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a urinary CD276 fragment for detecting resectable pancreatic cancer using a C-terminal proteomics strategy;Scientific Reports;2024-06-20

2. Identification of a urinary CD276 fragment for detecting resectable pancreatic cancer using a C-terminal proteomics strategy;2024-03-25

3. Molecular testing in pancreatic cancer;Diagnostic Molecular Pathology;2024

4. Mass Spectrometry-based Proteomics Technology in Pancreatic Cancer Research;Journal of Pancreatology;2023-11-14

5. Protein Biomarker Discovery Studies on Urinary sEV Fractions Separated with UF-SEC for the First Diagnosis and Detection of Recurrence in Bladder Cancer Patients;Biomolecules;2023-06-01